American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 11(63), 2019
DOI: 10.1128/aac.00448-19
Full text: Download
Trichomoniasis is a sexually transmitted disease with hundreds of millions of annual cases worldwide. Approved treatment options are limited to two related nitro-heterocyclic compounds, yet resistance to these drugs is an increasing concern. New antimicrobials against the causative agent, Trichomonas vaginalis , are urgently needed.